| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |